Hansa Biopharma to present at the 39th Annual J.P. Morgan Healthcare Conference
The J.P. Morgan Healthcare Conference, the largest investment conference in the life science industry, will take place January 11-14, 2021Lund, Sweden December 23, 2020. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company’s management team will present at the 39th Annual J.P. Morgan Healthcare Conference 2021. The company presentation will take place virtually Thursday January 14, 2021 at 7:30 am (EST)/13:30 (CET). Management will outline Hansa Biopharma’s proprietary enzyme technology platform as well as